A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

Clinical trial NCT03819881 · UNKNOWN

Trial details

NCT number: NCT03819881
Sponsor: Siolta Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Immunoglobulin E-Mediated Allergic Disorder

Start date: 2018-10-10
Primary completion: 2019-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.